207 related articles for article (PubMed ID: 35183358)
1. ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations.
Sawhney MS; Calderwood AH; Thosani NC; Rebbeck TR; Wani S; Canto MI; Fishman DS; Golan T; Hidalgo M; Kwon RS; Riegert-Johnson DL; Sahani DV; Stoffel EM; Vollmer CM; Qumseya BJ;
Gastrointest Endosc; 2022 May; 95(5):817-826. PubMed ID: 35183358
[No Abstract] [Full Text] [Related]
2. American Society for Gastrointestinal Endoscopy guideline on screening for pancreatic cancer in individuals with genetic susceptibility: methodology and review of evidence.
Calderwood AH; Sawhney MS; Thosani NC; Rebbeck TR; Wani S; Canto MI; Fishman DS; Golan T; Hidalgo M; Kwon RS; Riegert-Johnson DL; Sahani DV; Stoffel EM; Vollmer CM; Al-Haddad MA; Amateau SK; Buxbaum JL; DiMaio CJ; Fujii-Lau LL; Jamil LH; Jue TL; Law JK; Lee JK; Naveed M; Pawa S; Storm AC; Qumseya BJ
Gastrointest Endosc; 2022 May; 95(5):827-854.e3. PubMed ID: 35183359
[No Abstract] [Full Text] [Related]
3. How I Approach Screening for Pancreatic Cancer.
de la Fuente J; Kastrinos F; Majumder S
Am J Gastroenterol; 2021 Aug; 116(8):1569-1571. PubMed ID: 34047301
[No Abstract] [Full Text] [Related]
4. Review of screening for pancreatic cancer in high risk individuals.
Stoita A; Penman ID; Williams DB
World J Gastroenterol; 2011 May; 17(19):2365-71. PubMed ID: 21633635
[TBL] [Abstract][Full Text] [Related]
5. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.
Goggins M; Overbeek KA; Brand R; Syngal S; Del Chiaro M; Bartsch DK; Bassi C; Carrato A; Farrell J; Fishman EK; Fockens P; Gress TM; van Hooft JE; Hruban RH; Kastrinos F; Klein A; Lennon AM; Lucas A; Park W; Rustgi A; Simeone D; Stoffel E; Vasen HFA; Cahen DL; Canto MI; Bruno M;
Gut; 2020 Jan; 69(1):7-17. PubMed ID: 31672839
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts.
Lucas AL; Frado LE; Hwang C; Kumar S; Khanna LG; Levinson EJ; Chabot JA; Chung WK; Frucht H
Cancer; 2014 Jul; 120(13):1960-7. PubMed ID: 24737347
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer and cancer screening programs: from nihilism to hope.
Pezzilli R; Corinaldesi R; Morselli-Labate AM
JOP; 2010 Nov; 11(6):654-5. PubMed ID: 21068511
[No Abstract] [Full Text] [Related]
8. Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial?
Torphy RJ; Schulick RD
Surg Clin North Am; 2018 Feb; 98(1):25-35. PubMed ID: 29191275
[TBL] [Abstract][Full Text] [Related]
9. Should This Patient Be Screened for Pancreatic Cancer? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
Reynolds EE; Doubeni CA; Sawhney MS; Kanjee Z
Ann Intern Med; 2020 Dec; 173(11):914-921. PubMed ID: 33253616
[TBL] [Abstract][Full Text] [Related]
10. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.
Aslanian HR; Lee JH; Canto MI
Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142
[TBL] [Abstract][Full Text] [Related]
11. Screening patients at high risk for pancreatic cancer-Is it time for a paradigm shift?
Lo W; Morris MC; Ahmad SA; Patel SH
J Surg Oncol; 2019 Oct; 120(5):851-857. PubMed ID: 31309569
[TBL] [Abstract][Full Text] [Related]
12. Recommendations for a More Organized and Effective Approach to the Early Detection of Pancreatic Cancer From the PRECEDE (Pancreatic Cancer Early Detection) Consortium.
Gonda TA; Everett JN; Wallace M; Simeone DM;
Gastroenterology; 2021 Dec; 161(6):1751-1757. PubMed ID: 34454916
[No Abstract] [Full Text] [Related]
13. Inherited Pancreatic Cancer Syndromes and High-Risk Screening.
Biller LH; Wolpin BM; Goggins M
Surg Oncol Clin N Am; 2021 Oct; 30(4):773-786. PubMed ID: 34511196
[TBL] [Abstract][Full Text] [Related]
14. Identification and screening of individuals at increased risk for pancreatic cancer with emphasis on known environmental and genetic factors and hereditary syndromes.
Chu D; Kohlmann W; Adler DG
JOP; 2010 May; 11(3):203-12. PubMed ID: 20442513
[TBL] [Abstract][Full Text] [Related]
15. Advances in counselling and surveillance of patients at risk for pancreatic cancer.
Brand RE; Lerch MM; Rubinstein WS; Neoptolemos JP; Whitcomb DC; Hruban RH; Brentnall TA; Lynch HT; Canto MI;
Gut; 2007 Oct; 56(10):1460-9. PubMed ID: 17872573
[TBL] [Abstract][Full Text] [Related]
16. "PancPro" as a tool for selecting families eligible for pancreatic cancer screening: an Italian study of incident cases.
Leonardi G; Marchi S; Falconi M; Zerbi A; Ussia V; de Bortoli N; Mosca F; Presciuttini S; Del Chiaro M
Dig Liver Dis; 2012 Jul; 44(7):585-8. PubMed ID: 22281375
[TBL] [Abstract][Full Text] [Related]
17. Surveillance for neoplasia in the pancreas.
Overbeek KA; Cahen DL; Canto MI; Bruno MJ
Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):971-986. PubMed ID: 27938791
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation.
Vasen HF; Wasser M; van Mil A; Tollenaar RA; Konstantinovski M; Gruis NA; Bergman W; Hes FJ; Hommes DW; Offerhaus GJ; Morreau H; Bonsing BA; de Vos tot Nederveen Cappel WH
Gastroenterology; 2011 Mar; 140(3):850-6. PubMed ID: 21129377
[TBL] [Abstract][Full Text] [Related]
19. Screening for pancreatic cancer in familial high-risk individuals: A systematic review.
Lu C; Xu CF; Wan XY; Zhu HT; Yu CH; Li YM
World J Gastroenterol; 2015 Jul; 21(28):8678-86. PubMed ID: 26229410
[TBL] [Abstract][Full Text] [Related]
20. [Early detection of sporadic pancreatic cancer].
Frič P; Šedo A; Škrha J; Zima T; Bušek P; Škrha P; Kmochová K; Laclav M; Bunganič B; Zavoral M
Cas Lek Cesk; 2016; 155(1):44-7. PubMed ID: 26898791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
